Stanton Glantz blog

Commentary on tobacco, cannabis and public health

FDA should extend the scope of its proposed cigar flavor standard to prohibit flavors in all tobacco products, including e-cigarettes and smokeless tobacco, to make them less appealing to adolescents and young adults

My colleagues at the UCSF TCORS and I submitted this public comment to the FDA on its proposal to remove flavors from cigars. A PDF of the comment is here. The Regulations.gov tracking number is l6c-lwj1-vcu7. FDA should extend the scope of the proposed flavor standard to prohibit flavors in all tobacco products, including e-cigarettesContinue reading “FDA should extend the scope of its proposed cigar flavor standard to prohibit flavors in all tobacco products, including e-cigarettes and smokeless tobacco, to make them less appealing to adolescents and young adults”

FDA should not grant exemptions to its proposed standard banning menthol in cigarettes that would continue to allow menthol heated tobacco products or low nicotine cigarettes

FDA’s proposed standard banning menthol in cigarettes is very well-done except for its provision that would allow FDA to exempt heated tobacco products like Philip Morris’ IQOS, BAT’s glo or JTI’s Ploom — which are considered “cigarettes” under the law — or low nicotine cigarettes. (FDA has only authorized sale IQOS so far.) This isContinue reading “FDA should not grant exemptions to its proposed standard banning menthol in cigarettes that would continue to allow menthol heated tobacco products or low nicotine cigarettes”

FDA should prohibit all menthol flavor additives, compounds, constituents, and ingredients in cigarettes, and should not limit the proposed standard to prohibiting menthol as a “characterizing flavor”

My colleagues at UCSF and other universities and I have submitted this comment to the FDA in response to its proposal to prohibit the use of menthol in cigarettes. A PDF of the comment is here. The Regulations.gov tracking number is l6b-ew3y-c1ye. FDA should prohibit all menthol flavor additives, compounds, constituents, and ingredients in cigarettes,Continue reading “FDA should prohibit all menthol flavor additives, compounds, constituents, and ingredients in cigarettes, and should not limit the proposed standard to prohibiting menthol as a “characterizing flavor””

Another organ e-cigs adversely affect: blood

Yao Wang and colleagues compared the results of the Complete Blood Count (CBC), a routine blood tests used in clinical practice to diagnose a range of conditions, among participants in the US National Health and Nutrition Examination Survey (NHANES). In contrast to most national health survey, NHANES includes in person clinical tests on participants. TheirContinue reading “Another organ e-cigs adversely affect: blood”

FDA science leader Matt Holman leaves FDA for PMI

Matt Holman, who has served as head of the FDA Center for Tobacco Products since 2017, is leaving the FDA to take a job with Philip Morris International. According to a story in The Hill, a spokesperson for Philip Morris said Holman “is committed to helping existing adult smokers access scientifically substantiated smoke-free alternatives whileContinue reading “FDA science leader Matt Holman leaves FDA for PMI”

First epidemiological evidence linking e-cigs to cancer in people

E-cigarette advocates like to point out that because there is no combustion, e-cigarettes expose users to lower levels of many carcinogens (cancer-causing chemicals).  Even so, there are still some carcinogens in e-cigarette aerosol exposure to e-cigarette aerosol damages DNA and reduces repair in animal and human cells and causes cancer in animals.  Now there isContinue reading “First epidemiological evidence linking e-cigs to cancer in people”

Here’s an approachable introduction to the growing collection of industry insider documents on opioids, free to all

Caleb Alexander, together with colleagues at Johns Hopkins, UCSF and I just published “The Opioid Industry Documents Archive: A Living Digital Repository” in American Journal of Public Health. This paper describes the growing Opioid Industry Documents Archive that is part of the UCSF Industry Documents Library and outlines opportunities for research and public education withContinue reading “Here’s an approachable introduction to the growing collection of industry insider documents on opioids, free to all”

Outside review of FDA CTP operations brings opportunities and risks

FDA Commissioner Rob Califf announced (Politico, Associated Press, New York Times) that he was asking the Regan-Udall Foundation to conduct a process review of the FDA’s tobacco and food centers. As someone who has been critical of the poor and incomplete scientific assessments FDA has completed of so-called “harm reduction” products — particularly e-cigarettes andContinue reading “Outside review of FDA CTP operations brings opportunities and risks”

Since FDA has made a mess of Juul, the health community & Congress should force FDA to ban menthol e-cigs now

The day after FDA denied Juul’s application to continue selling its e-cigarettes on June 23, 2022, Juul sued and obtained an emergency Stay from the US Court of Appeals.  On July 5, the FDA announced that it was issuing its own Administrative Stay and allowed Juul to remain on the market while the FDA considersContinue reading “Since FDA has made a mess of Juul, the health community & Congress should force FDA to ban menthol e-cigs now”

Loading…

Something went wrong. Please refresh the page and/or try again.


Follow My Blog

Get new content delivered directly to your inbox.

%d bloggers like this: